Search

Your search keyword '"Zhu, Zhoujing"' showing total 48 results
Start Over Author "Zhu, Zhoujing"
48 results on '"Zhu, Zhoujing"'

4. Crystal structure of 2-((2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-(2-(4-methylpiperazin-1-yl)ethyl)benzamide hydrate, C25H37Cl2N5O6

Author

Xu Xiaona, Tang Wenqiang, Zhu Zhoujing, and Liu Bin

Subjects
2294528, Physics, QC1-999, Crystallography, QD901-999
Abstract

C25H37Cl2N5O6, triclinic, P1‾ $P\overline{1}$ (no. 2), a = 8.115(4) Å, b = 8.656(4) Å, c = 22.641(9) Å, α = 81.344(9)°, β = 80.173(9)°, γ = 65.833(8)°, V = 1423.9(10) Å3, Z = 2, R gt(F) = 0.0652, wR ref(F 2) = 0.2010, T = 173 K.

Published
2024
Full Text
View/download PDF

5. Crystal structure of 3-(5-((4-(difluoromethoxy)phenyl) sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl) oxetane-3-carboxamide, C17H19F2N3O5S

Author

Liu Bin, Xu Xiaona, Tong Hongjuan, Wang Yanjiao, and Zhu Zhoujing

Subjects
2294646, Physics, QC1-999, Crystallography, QD901-999
Abstract

C17H19F2N3O5S, monoclinic, P21/c (no. 14), a = 14.157(7) Å, b = 11.133(6) Å, c = 11.400(6) Å, β = 91.965(13)°, V = 1795.6(16) Å3, Z = 4, Rgt(F) = 0.0611 wRref(F2) = 0.1809, T = 205 K.

Published
2024
Full Text
View/download PDF

7. Crystal structure of 1-(2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)-1,2-dihydro-4H-benzo[d][1,3]oxazin-4-one, C19H14Cl2N2O3

Author

Zhu Zhoujing, Zhang Cuiya, Xu Xiaona, and Tang Wenqiang

Subjects
2292590, Physics, QC1-999, Crystallography, QD901-999
Abstract

C19H14Cl2N2O3, monoclinic, P21/c (no. 14), a = 10.635(3) Å, b = 8.772(3) Å, c = 19.656(6) Å, β = 98.256(10)°, V = 1814.8(10) Å3, Z = 4, Rgt(F) = 0.0602, wRref(F2) = 0.1547, T = 205 K.

Published
2024
Full Text
View/download PDF

11. Crystal structure of methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H21ClN2O5

Author

Xu Xiaona, Zhu Zhoujing, and Liu Bin

Subjects
1862538, Physics, QC1-999, Crystallography, QD901-999
Abstract

C23H21ClN2O5, monoclinic, P21/c (no. 14), a = 9.191(3) Å, b = 10.725(5) Å, c = 11.2390(10) Å, β = 109.869(13)°, V = 1041.9(6) Å3, Z = 2, Rgt(F) = 0.0609, wRref(F2) = 0.1695, T = 293 K.

Published
2023
Full Text
View/download PDF

14. Hunting Metabolic Biomarkers for Exposure to Per- and Polyfluoroalkyl Substances: A Review.

Author

Ma, Xue, Cai, Delei, Chen, Qing, Zhu, Zhoujing, Zhang, Shixin, Wang, Ziyu, Hu, Zhengyan, Shen, Haitao, and Meng, Zhen

Subjects
FLUOROALKYL compounds, POLLUTANTS, PERSISTENT pollutants, CARDIOTOXICITY, NEPHROTOXICOLOGY
Abstract

Per- and polyfluoroalkyl substances (PFAS) represent a class of persistent synthetic chemicals extensively utilized across industrial and consumer sectors, raising substantial environmental and human health concerns. Epidemiological investigations have robustly linked PFAS exposure to a spectrum of adverse health outcomes. Altered metabolites stand as promising biomarkers, offering insights into the identification of specific environmental pollutants and their deleterious impacts on human health. However, elucidating metabolic alterations attributable to PFAS exposure and their ensuing health effects has remained challenging. In light of this, this review aims to elucidate potential biomarkers of PFAS exposure by presenting a comprehensive overview of recent metabolomics-based studies exploring PFAS toxicity. Details of PFAS types, sources, and human exposure patterns are provided. Furthermore, insights into PFAS-induced liver toxicity, reproductive and developmental toxicity, cardiovascular toxicity, glucose homeostasis disruption, kidney toxicity, and carcinogenesis are synthesized. Additionally, a thorough examination of studies utilizing metabolomics to delineate PFAS exposure and toxicity biomarkers across blood, liver, and urine specimens is presented. This review endeavors to advance our understanding of PFAS biomarkers regarding exposure and associated toxicological effects. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Crystal structure of 2-((2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-(2-(4-methylpiperazin-1-yl)ethyl)benzamide hydrate, C25H37Cl2N5O6.

Author

Xu, Xiaona, Tang, Wenqiang, Zhu, Zhoujing, and Liu, Bin

Subjects
CRYSTAL structure, BENZAMIDE
Abstract

C25H37Cl2N5O6, triclinic, P 1 ‾ (no. 2), a = 8.115(4) Å, b = 8.656(4) Å, c = 22.641(9) Å, α = 81.344(9)°, β = 80.173(9)°, γ = 65.833(8)°, V = 1423.9(10) Å3, Z = 2, Rgt(F) = 0.0652, wRref(F2) = 0.2010, T = 173 K. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

22. Crystal structure of 3-(5-((4-(difluoromethoxy)phenyl) sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl) oxetane-3-carboxamide, C17H19F2N3O5S.

Author

Liu, Bin, Xu, Xiaona, Tong, Hongjuan, Wang, Yanjiao, and Zhu, Zhoujing

Subjects
CRYSTAL structure
Abstract

C17H19F2N3O5S, monoclinic, P21/c (no. 14), a = 14.157(7) Å, b = 11.133(6) Å, c = 11.400(6) Å, β = 91.965(13)°, V = 1795.6(16) Å3, Z = 4, Rgt(F) = 0.0611 wRref(F2) = 0.1809, T = 205 K. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. Crystal structure of C10H10O4

Author

Tang, Wenqiang, primary, Xu, Xiaona, additional, Gao, Yanrong, additional, Tong, Hongjuan, additional, Zhu, Zhoujing, additional, and Liu, Bin, additional

Published
2022
Full Text
View/download PDF

28. Crystal structure of 1-(2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)-1,2-dihydro-4H-benzo[d][1,3]oxazin-4-one, C19H14Cl2N2O3.

Author

Zhu, Zhoujing, Zhang, Cuiya, Xu, Xiaona, and Tang, Wenqiang

Subjects
*CRYSTAL structure, *OSMIUM
Abstract

C19H14Cl2N2O3, monoclinic, P21/c (no. 14), a = 10.635(3) Å, b = 8.772(3) Å, c = 19.656(6) Å, β = 98.256(10)°, V = 1814.8(10) Å3, Z = 4, Rgt(F) = 0.0602, wRref(F2) = 0.1547, T = 205 K. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Crystal structure of 1-(2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)-1,2-dihydro-4H-benzo[d][1,3]oxazin-4-one, C19H14Cl2N2O3.

Author

Zhu, Zhoujing, Zhang, Cuiya, Xu, Xiaona, and Tang, Wenqiang

Subjects
CRYSTAL structure, OSMIUM
Abstract

C19H14Cl2N2O3, monoclinic, P21/c (no. 14), a = 10.635(3) Å, b = 8.772(3) Å, c = 19.656(6) Å, β = 98.256(10)°, V = 1814.8(10) Å3, Z = 4, Rgt(F) = 0.0602, wRref(F2) = 0.1547, T = 205 K. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

40. Crystal structure of (<italic>Z</italic>)-4-amino-<italic>N</italic>′-((4-chlorophenyl)(phenyl)methylene)benzohydrazide, C20H16ClN3O.

Author

Song, Yanli, Du, Mo, Zhu, Zhoujing, Tang, Wenqiang, and Tong, Hongjuan

Abstract

C20H16ClN3O, monoclinic, I2/a (no. 15), a = 16.3816(6) Å, b = 15.3173(5) Å, c = 27.7833(14) Å, β = 92.800(2)°, V = 6,963.1(5) Å3, Z = 8, Rgt(F) = 0.0375, wRref(F2) = 0.1061, T = 299 K. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

43. Crystal structure of 2-((2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-(2-(4-methylpiperazin-1-yl)ethyl)benzamide hydrate, C25H37Cl2N5O6.

Author

Xu, Xiaona, Tang, Wenqiang, Zhu, Zhoujing, and Liu, Bin

Subjects
*CRYSTAL structure, *BENZAMIDE
Abstract

C25H37Cl2N5O6, triclinic, P 1 ‾ (no. 2), a = 8.115(4) Å, b = 8.656(4) Å, c = 22.641(9) Å, α = 81.344(9)°, β = 80.173(9)°, γ = 65.833(8)°, V = 1423.9(10) Å3, Z = 2, Rgt(F) = 0.0652, wRref(F2) = 0.2010, T = 173 K. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results